NCT02237196: A trial that was reported late by National Institute of Allergy and Infectious Diseases (NIAID)
This trial has reported, although it was 14 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT02237196 |
|---|---|
| Title | Anti-TSLP (AMG 157) Plus Antigen-Specific Immunotherapy for Induction of Tolerance in Individuals With Cat Allergy (ITN057AD) |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | March 3, 2015 |
| Completion date | March 4, 2019 |
| Required reporting date | March 3, 2020, midnight |
| Actual reporting date | March 18, 2020 |
| Date last checked at ClinicalTrials.gov | March 28, 2025 |
| Days late | 14 |